Search alternatives:
linear decrease » linear increase (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
Showing 2,261 - 2,280 results of 226,405 for search '(( a ((((laser decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.36s Refine Results
  1. 2261
    Image_5_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIF

    Image_5_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  2. 2262
    Image_10_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_10_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  3. 2263
    Image_2_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_2_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  4. 2264
    Image_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  5. 2265
    Image_7_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_7_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  6. 2266
    Table_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.xls

    Table_1_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.xls by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  7. 2267
    Image_8_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_8_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  8. 2268
    Image_4_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_4_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  9. 2269
    Image_6_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF

    Image_6_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

    Published 2021
    “…Background<p>Cachexia is defined as an involuntary decrease in body weight, which can increase the risk of death in cancer patients and reduce the quality of life. …”
    Save to List
    Saved in:
  10. 2270
    Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.

    Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations. by Kimmo Sorjonen (495847)

    Published 2025
    “…<p>Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.…”
    Save to List
    Saved in:
  11. 2271
    Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation.

    Aggrecan knockdown ATDC5 chondroprogenitor cells have decreased Alcian blue staining and absorbance levels compared to control cells after ITS stimulation. by Juanita K. Hodax (6848540)

    Published 2019
    Save to List
    Saved in:
  12. 2272
    Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils.

    Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils. by Jian Hao (160736)

    Published 2013
    “…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”
    Save to List
    Saved in:
  13. 2273
    GSK360A increased kidney EPO and brain VEGF mRNA after stroke.

    GSK360A increased kidney EPO and brain VEGF mRNA after stroke. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  14. 2274
    Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke.

    Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  15. 2275
    The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage.

    The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  16. 2276
    Body weight was measured over the course of the study.

    Body weight was measured over the course of the study. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  17. 2277
    TTC staining of forebrain 2 mm thick sections conducted 4 weeks after tMCAO stroke (1 week after APA testing).

    TTC staining of forebrain 2 mm thick sections conducted 4 weeks after tMCAO stroke (1 week after APA testing). by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  18. 2278
    Overall schematic of basic experimental studies and designs.

    Overall schematic of basic experimental studies and designs. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  19. 2279
    The chemical structure and the enzymatic and cellular activity of GSK360A.

    The chemical structure and the enzymatic and cellular activity of GSK360A. by Jin Zhou (90734)

    Published 2017
    Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
    Save to List
    Saved in:
  20. 2280
    HbA1c by BMI for new and previous diabetes diagnoses at start of TB treatment.

    HbA1c by BMI for new and previous diabetes diagnoses at start of TB treatment. by Sharon E. Cox (7243847)

    Published 2021
    Save to List
    Saved in:

Search Tools: